{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-21-153559","form_type":"8-K","ticker":"HUMA","cik":"0001818382","company_name":"Humacyte, Inc.","filed_at":"2021-12-27T23:59:59+00:00","discovered_at":"2026-05-14T18:04:14.305595+00:00","generated_at":"2026-06-27T22:23:11.503520+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Humacyte CSO Jeffrey Lawson to depart effective Dec 31, 2022; no disagreement cited","bullets":["Dr. Jeffrey H. Lawson, Chief Surgical Officer, leaves Humacyte effective Dec 31, 2022, and resigns from board.","Departure is mutual, not due to any disagreement with company operations, policies, or practices.","Severance benefits per existing employment agreement; vested stock option exercise period extended to Nov 26, 2022.","Separation agreement includes customary release of claims and supersedes other severance arrangements."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-21-153559","json":"https://secwatch.observer/filing/0001104659-21-153559.json","markdown":"https://secwatch.observer/filing/0001104659-21-153559.md","text":"https://secwatch.observer/filing/0001104659-21-153559.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1818382/000110465921153559/0001104659-21-153559-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1818382/000110465921153559/tm2136325d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T22:23:11.503520+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"651ea53698","claim":"Jeffrey H. Lawson resigned as Director at Humacyte, Inc..","evidence_excerpt":"Dr. Lawson also resigned from the Company’s board of directors, effective as of the Separation Date.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1818382/000110465921153559/0001104659-21-153559-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"c6dfb083ce","claim":"Jeffrey H. Lawson resigned as Chief Surgical Officer at Humacyte, Inc..","evidence_excerpt":"On December 23, 2021, Humacyte, Inc. (the “Company”) and Jeffrey H. Lawson, M.D., Ph.D., the Company’s Chief Surgical Officer, mutually agreed to end Dr. Lawson’s employment with the Company, effective December 31, 2022 (the “Separation Date”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1818382/000110465921153559/0001104659-21-153559-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Surgical Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}